The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

BULK, Saskia; Berkhof, J.; Rozendaal, L.; Fransen Daalmeijer, N. C.; Gok, M.; de Schipper, F. A.; van Kemenade, F. J.; Snijders, P. J. F.; Meijer, C. J. L. M.

doi:10.1038/sj.bjc.6603693

Article (Scientific journals)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

BULK, Saskia; Berkhof, J.; Rozendaal, L. et al.

2007 • In British Journal of Cancer, 96 (8), p. 1234-6

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/181846

DOI
10.1038/sj.bjc.6603693

PubMed
17375047

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Bulk 12.pdf

Publisher postprint (77.7 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell/virology; Cervical Intraepithelial Neoplasia/virology; Cross-Sectional Studies; Female; Human papillomavirus 18/isolation & purification; Humans; Middle Aged; Uterine Cervical Neoplasms/virology

Abstract :

[en] In one geographical area, 14 high-risk human papillomavirus types in cervical intraepithelial neoplasia (CIN2/3; n=139) and cervical squamous cell carcinoma (SCC; n=84) were analysed. HPV18 was more prevalent in SCC than CIN2/3 (OR 9.8; 95% confidence interval: 2.5-39). Other high-risk types prevalences corresponded in CIN2/3 and SCC. Evaluations using CIN2/3 as a measure of efficiency underestimate the contribution of HPV18 to SCC.

Disciplines :

Genetics & genetic processes

Author, co-author :

BULK, Saskia ; Centre Hospitalier Universitaire de Liège - CHU > Génétique

Berkhof, J.

Rozendaal, L.

Fransen Daalmeijer, N. C.

Gok, M.

de Schipper, F. A.

van Kemenade, F. J.

Snijders, P. J. F.

Meijer, C. J. L. M.

Language :

English

Title :

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

Publication date :

2007

Journal title :

British Journal of Cancer

ISSN :

0007-0920

eISSN :

1532-1827

Publisher :

Nature Publishing Group, United Kingdom

Volume :

Issue :

Pages :

1234-6

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 23 May 2015

Statistics

Number of views

57 (0 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Berkhof J, Bulkmans NW, Bleeker MCG, Bulk S, Snijders PJF, Voorhorst FJ, Meijer CJLM (2006) HPV type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev 15: 1268-1273
Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, van Kemenade FJ, Snijders PJ, Meijer CJ (2006) Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer 94: 171-175
Bulkmans NW, Bleeker MC, Berkhof J, Voorhorst FJ, Snijders PJ, Meijer CJ (2005) Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer 117: 177-181
Castle PE, Solomon D, Schiffman M, Wheeler CM (2005) Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 97: 1066-1071
Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL (2006) Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24Suppl 3: S26-S34
Clifford GM, Smith JS, Aguado T, Franceschi S (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89: 101-105
Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM (1997) A general primer GP5+/GP6(+)-mediated PCRenzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35: 791-795
Jacobs MV, Zielinski D, Meijer CJ, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJ, Walboomers JM (2000) A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 82: 1421-1426
Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL (2003) High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 71: 265-273
Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97: 1072-1079
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527
Roda Husman AM, Walboomers JM, Meijer CJ, Risse EK, Schipper ME, Helmerhorst TM, Bleker OP, Delius H, van den Brule AJ, Snijders PJ (1994) Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 56: 802-806
Rosenbaum PR (1991) Discussing hidden bias in observational studies. Ann Intern Med 115: 901-905
van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779-787
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
Woodman CB, Collins S, Rollason TP, Winter H, Bailey A, Yates M, Young LS (2003) Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet 361: 40-43
Zuna RE, Allen RA, Moore WE, Mattu R, Dunn ST (2004) Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol 17: 1314-1322